Clinical Trials Browser

Phase 1 × acalabrutinib × Plasma cell × Clear all

NCT02211014 2020-07-31

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Phase 1 Completed

27 enrolled 13 charts

Multiple Myeloma